Cytosorbents Corp | Business Contracts

Sixth Amendment to the Amended and Restated Loan and Security Agreement, dated as of March 8, 2023, by and among CytoSorbents Corporation, CytoSorbents Medical, Inc. and Western... (Filed With SEC on March 9, 2023)

Marketing Agreement, by and between the Company and Fresenius Medical Care Deutschland GmbH, dated as of August 1, 2022 (Filed With SEC on November 3, 2022)

Success Fee Letter between the Borrower and the Bank, dated January 19, 2022 (Filed With SEC on January 20, 2022)

Lease, dated as of March 26, 2021, by and between 300 CR LLC and CytoSorbents Medical Inc (Filed With SEC on March 31, 2021)

Employment Agreement by and between the Company and Efthymios Deliargyris, M.D., dated April 12, 2020 (Filed With SEC on April 27, 2020)

Assignment and Assumption of Certain Royalty Rights, dated as of November 22, 2022, by and among Robert Shipley Living Trust, ROKK, LLC, and CytoSorbents Medical, Inc (Filed With SEC on March 9, 2023)

Fifth Amendment to the Amended and Restated Loan and Security Agreement, dated December 28, 2022 (Filed With SEC on December 29, 2022)

Description of Capital Stock of CytoSorbents Corporation (Filed With SEC on March 10, 2022)

Fourth Amendment to the Amended and Restated Loan and Security Agreement, dated January 19, 2022 (Filed With SEC on January 20, 2022)

Open Market Sale AgreementSM, dated December 30, 2021, by and between CytoSorbents Corporation and Jefferies LLC (Filed With SEC on December 30, 2021)

Third Amendment to the Amended and Restated Loan and Security Agreement, dated December 4, 2020 (Filed With SEC on December 10, 2020)

Nineteenth Amendment to Lease Agreement by and between the Registrant and Princeton Corporate Plaza, LLC, dated April 16, 2020 (Filed With SEC on August 4, 2020)

Underwriting Agreement, by and among the Company and the Underwriters, dated as of July 21, 2020 (Filed With SEC on July 22, 2020)

Amendment No. 1 to Open Market Sale AgreementSM, dated as of April 20, 2020, by and among CytoSorbents Corporation, Jefferies LLC and B. Riley FBR, Inc (Filed With SEC on April 20, 2020)

Description of Capital Stock of CytoSorbents Corporation (Filed With SEC on March 5, 2020)

Separation Agreement and Release, dated December 9, 2019, by and between CytoSorbents Corporation and Dr. Eric Mortensen (Filed With SEC on December 12, 2019)

Eighteenth Amendment to Lease Agreement by and between the Registrant and Princeton Corporate Plaza, LLC, dated January 4, 2019 (Filed With SEC on August 6, 2019)

First Amendment to the Amended and Restated Loan and Security Agreement (Filed With SEC on August 5, 2019)

Amended and Restated Employment Agreement, dated as of July 30, 2019, by and between CytoSorbents Medical, Inc. and Kathleen P. Bloch (Filed With SEC on August 5, 2019)

Amended and Restated Employment Agreement, dated as of July 30 2019, by and between CytoSorbents Medical, Inc. and Vincent Capponi (Filed With SEC on August 5, 2019)

Amended and Restated Employment Agreement, dated as of July 30, 2019, by and between CytoSorbents Medical, Inc. and Phillip P. Chan (Filed With SEC on August 5, 2019)

Open Market Sale AgreementSM, dated July 9, 2019, by and among CytoSorbents Corporation, Jefferies LLC and B. Riley FBR, Inc (Filed With SEC on July 9, 2019)

Amendment to Exclusive Distribution Agreement, dated December 15, 2015, by and between CytoSorbents Europe GmbH and Aferetica s.r.l (Filed With SEC on March 7, 2019)

Exclusive Distribution Agreement, dated as of December 15, 2014, by and between CytoSorbents Europe GmbH and Aferetica s.r.l (Filed With SEC on March 7, 2019)

Cytosorbents Corp (24)